| Name | Safeway Pharmacy #2764 |
|---|---|
| Organization Name | Nai Saturn Eastern Llc |
| Location | 1451 Ritchie Hwy, Arnold, Maryland 21012 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 757-7792 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports.
Few Americans know what a "medical loss ratio" is, but a fierce struggle over how to calculate it under the new health care reform law will determine how much insurers must spend on patient care and how much they can retain for administration and profits. This is but one of many battles that will emerge as federal and state regulators develop regulations to implement reform (5/23).
In an article published in the journal Health Policy and Planning, Tamara Hafner and Jeremy Shiffman of the Department of Public Administration and Policy at American University examine the factors behind why "many organizations involved in global health have come to direct attention and resources to the issue of health systems strengthening," especially since 2005, according to the abstract. They "construct a case history and analyze the factors shaping and inhibiting global political attention for health systems strengthening," the abstract states.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Reps. Yvette Clarke (D-N.Y.), Donald Payne (D-N.J.), and Frederica Wilson (D-Fla.) write in a Huffington Post opinion piece that the "increasing gravity of the situation" of internally displaced persons (IDP) camps in Haiti "requires an urgent response.
› Verified 6 days ago
| NPI Number | 1134379795 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #2764 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1451 Ritchie Hwy, Arnold, MD 21012 |
| Phone Number | 410-757-7792 |
News Archive
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports.
Few Americans know what a "medical loss ratio" is, but a fierce struggle over how to calculate it under the new health care reform law will determine how much insurers must spend on patient care and how much they can retain for administration and profits. This is but one of many battles that will emerge as federal and state regulators develop regulations to implement reform (5/23).
In an article published in the journal Health Policy and Planning, Tamara Hafner and Jeremy Shiffman of the Department of Public Administration and Policy at American University examine the factors behind why "many organizations involved in global health have come to direct attention and resources to the issue of health systems strengthening," especially since 2005, according to the abstract. They "construct a case history and analyze the factors shaping and inhibiting global political attention for health systems strengthening," the abstract states.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Reps. Yvette Clarke (D-N.Y.), Donald Payne (D-N.J.), and Frederica Wilson (D-Fla.) write in a Huffington Post opinion piece that the "increasing gravity of the situation" of internally displaced persons (IDP) camps in Haiti "requires an urgent response.
› Verified 6 days ago
| NPI Number | 1396781902 |
| Organization Name | NAI SATURN EASTERN LLC |
| Doing Business As | SAFEWAY PHARMACY #2764 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1451 Ritchie Hwy, Arnold, MD 21012 |
| Phone Number | 410-757-7792 |
News Archive
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports.
Few Americans know what a "medical loss ratio" is, but a fierce struggle over how to calculate it under the new health care reform law will determine how much insurers must spend on patient care and how much they can retain for administration and profits. This is but one of many battles that will emerge as federal and state regulators develop regulations to implement reform (5/23).
In an article published in the journal Health Policy and Planning, Tamara Hafner and Jeremy Shiffman of the Department of Public Administration and Policy at American University examine the factors behind why "many organizations involved in global health have come to direct attention and resources to the issue of health systems strengthening," especially since 2005, according to the abstract. They "construct a case history and analyze the factors shaping and inhibiting global political attention for health systems strengthening," the abstract states.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Reps. Yvette Clarke (D-N.Y.), Donald Payne (D-N.J.), and Frederica Wilson (D-Fla.) write in a Huffington Post opinion piece that the "increasing gravity of the situation" of internally displaced persons (IDP) camps in Haiti "requires an urgent response.
› Verified 6 days ago
| NPI Number | 1427669597 |
| Organization Name | NAI SATURN EASTERN LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1451 Ritchie Hwy, Arnold, MD 21012 |
| Phone Number | 410-757-0242 |
News Archive
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports.
Few Americans know what a "medical loss ratio" is, but a fierce struggle over how to calculate it under the new health care reform law will determine how much insurers must spend on patient care and how much they can retain for administration and profits. This is but one of many battles that will emerge as federal and state regulators develop regulations to implement reform (5/23).
In an article published in the journal Health Policy and Planning, Tamara Hafner and Jeremy Shiffman of the Department of Public Administration and Policy at American University examine the factors behind why "many organizations involved in global health have come to direct attention and resources to the issue of health systems strengthening," especially since 2005, according to the abstract. They "construct a case history and analyze the factors shaping and inhibiting global political attention for health systems strengthening," the abstract states.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Reps. Yvette Clarke (D-N.Y.), Donald Payne (D-N.J.), and Frederica Wilson (D-Fla.) write in a Huffington Post opinion piece that the "increasing gravity of the situation" of internally displaced persons (IDP) camps in Haiti "requires an urgent response.
› Verified 6 days ago
News Archive
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports.
Few Americans know what a "medical loss ratio" is, but a fierce struggle over how to calculate it under the new health care reform law will determine how much insurers must spend on patient care and how much they can retain for administration and profits. This is but one of many battles that will emerge as federal and state regulators develop regulations to implement reform (5/23).
In an article published in the journal Health Policy and Planning, Tamara Hafner and Jeremy Shiffman of the Department of Public Administration and Policy at American University examine the factors behind why "many organizations involved in global health have come to direct attention and resources to the issue of health systems strengthening," especially since 2005, according to the abstract. They "construct a case history and analyze the factors shaping and inhibiting global political attention for health systems strengthening," the abstract states.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Reps. Yvette Clarke (D-N.Y.), Donald Payne (D-N.J.), and Frederica Wilson (D-Fla.) write in a Huffington Post opinion piece that the "increasing gravity of the situation" of internally displaced persons (IDP) camps in Haiti "requires an urgent response.
› Verified 6 days ago
Cvs Pharmacy # 03043 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1500 Ritchie Hwy, Arnold, Maryland 21012 Phone: (410) 757-3902 | |
Walgreens #17610 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1230 Bay Dale Dr, Arnold, Maryland 21012 Phone: (410) 757-0027 | |
Safeway Pharmacy #2764 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1451 Ritchie Hwy, Arnold, Maryland 21012 Phone: (410) 757-7792 |